CareCloud vs Definitive Healthcare
CCLD and DH side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CCLD and DH compare
Definitive Healthcare is the larger company, worth 1.2 times as much as CareCloud ($137M against $113M).
CareCloud grew revenue faster over the last twelve months (14.9% versus −6.2% for Definitive Healthcare).
CareCloud keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with −69.2% at Definitive Healthcare.
CareCloud scores higher on the StockData Score (12 against 5 for Definitive Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CCLD | DH |
|---|---|---|
| Size and price | ||
| Market cap | $113M | $137M |
| Share price | $2.65 | $1.28 |
| Change, 1 year | −21.4% | −55.1% |
| Change, 5 years | −63.1% | −96.3% |
| Beta (5Y) | 1.42 | 1.85 |
| Employees | 3,300 | 686 |
| StockData Score | ||
| Total score | 12 (better) | 5 |
| Valuation score | 3 | 3 |
| Growth score | 1 (better) | 0 |
| Performance score | 4 (better) | 0 |
| Health score | 4 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 20.4× | – |
| P/S | 0.9× | 0.6× (better) |
| P/B | 5.0× | – |
| EV/EBITDA | 3.9× | – |
| P/FCF | 5.2× (better) | 5.6× |
| FCF yield | 19.2% (better) | 17.7% |
| Fair value | $4.97 | $3.98 |
| Margin of safety | 46.7% | 67.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 14.9% (better) | −6.2% |
| Revenue growth, 5Y average | 2.8% | 15.3% (better) |
| Net income growth (TTM) | −13.8% | – |
| EPS growth (TTM) | 225% | – |
| Profitability | ||
| Gross margin | – | 75.4% |
| Operating margin | 9.6% (better) | −105% |
| Net margin | 7.4% (better) | −69.2% |
| FCF margin | 16.5% (better) | 10.6% |
| Return on equity | 24.0% | – |
| Return on invested capital | 33.8% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −22.2× |
| Current ratio | 0.87 | 1.96 (better) |
| Altman Z-score | 2.18 (better) | −3.24 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Buyback yield | – | 0.00% |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 22.5% | 81.2% |
| Held by insiders | 5.4% | – |
| Insider net buying, 12 months | $0 | – |
| Short interest, % of float | 1.7% | – |
Go deeper
- CCLD stock overview
- CCLD income statement
- CCLD valuation and score
- DH stock overview
- DH income statement
- DH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.